Certive Solutions Inc. (CBP.CN)
CAD 0.01
(0.0%)
CAD 0.01
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2022 | -2.1 Million USD | 29.83% |
| 2021 | -2.99 Million USD | -18.45% |
| 2020 | -2.52 Million USD | -37.41% |
| 2019 | -1.83 Million USD | 15.49% |
| 2018 | -2.17 Million USD | 27.06% |
| 2017 | -2.98 Million USD | 21.1% |
| 2016 | -3.78 Million USD | 22.87% |
| 2015 | -4.9 Million USD | -193.69% |
| 2014 | -1.66 Million USD | -14.41% |
| 2013 | -1.45 Million USD | -67.91% |
| 2012 | -869.24 Thousand USD | -29.72% |
| 2011 | -670.09 Thousand USD | -381.91% |
| 2010 | -139.05 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 Q2 | -530.47 Thousand USD | -20.44% |
| 2023 Q1 | -440.45 Thousand USD | 25.21% |
| 2023 Q3 | -445.37 Thousand USD | 16.04% |
| 2022 Q4 | -588.88 Thousand USD | -26.47% |
| 2022 Q2 | -465.89 Thousand USD | 19.74% |
| 2022 Q3 | -465.61 Thousand USD | 0.06% |
| 2022 FY | -2.1 Million USD | 29.83% |
| 2022 Q1 | -580.5 Thousand USD | 46.31% |
| 2021 Q4 | -1.08 Million USD | -39.29% |
| 2021 Q1 | -565.75 Thousand USD | 24.92% |
| 2021 FY | -2.99 Million USD | -18.45% |
| 2021 Q2 | -570.84 Thousand USD | -0.9% |
| 2021 Q3 | -776.22 Thousand USD | -35.98% |
| 2020 Q4 | -753.54 Thousand USD | -18.96% |
| 2020 Q3 | -633.42 Thousand USD | -2.35% |
| 2020 Q2 | -618.85 Thousand USD | -136.06% |
| 2020 Q1 | -262.16 Thousand USD | 43.18% |
| 2020 FY | -2.52 Million USD | -37.41% |
| 2019 Q3 | -446.91 Thousand USD | -16.21% |
| 2019 Q2 | -384.56 Thousand USD | 20.04% |
| 2019 FY | -1.83 Million USD | 15.49% |
| 2019 Q1 | -480.94 Thousand USD | 41.31% |
| 2019 Q4 | -461.42 Thousand USD | -3.25% |
| 2018 Q3 | -604.52 Thousand USD | -63.25% |
| 2018 Q2 | -370.3 Thousand USD | 41.54% |
| 2018 Q4 | -819.48 Thousand USD | -35.56% |
| 2018 Q1 | -633.44 Thousand USD | 26.1% |
| 2018 FY | -2.17 Million USD | 27.06% |
| 2017 Q3 | -43.03 Thousand USD | 94.31% |
| 2017 FY | -2.98 Million USD | 21.1% |
| 2017 Q4 | -857.2 Thousand USD | -1891.74% |
| 2017 Q2 | -756.35 Thousand USD | -9.91% |
| 2017 Q1 | -688.18 Thousand USD | 68.88% |
| 2016 FY | -3.78 Million USD | 22.87% |
| 2016 Q4 | -2.21 Million USD | -235.91% |
| 2016 Q2 | -622.98 Thousand USD | -114.65% |
| 2016 Q1 | -290.23 Thousand USD | 89.81% |
| 2016 Q3 | -658.23 Thousand USD | -5.66% |
| 2015 FY | -4.9 Million USD | -193.69% |
| 2015 Q2 | -942.67 Thousand USD | -274.98% |
| 2015 Q3 | -861.09 Thousand USD | 8.65% |
| 2015 Q4 | -2.84 Million USD | -230.86% |
| 2015 Q1 | -251.39 Thousand USD | 72.71% |
| 2014 Q2 | -311.64 Thousand USD | -349.85% |
| 2014 FY | -1.66 Million USD | -14.41% |
| 2014 Q4 | -921.28 Thousand USD | -108.95% |
| 2014 Q3 | -440.9 Thousand USD | -41.48% |
| 2014 Q1 | -69.27 Thousand USD | 85.11% |
| 2013 Q4 | -465.25 Thousand USD | -23.51% |
| 2013 FY | -1.45 Million USD | -67.91% |
| 2013 Q1 | -442.61 Thousand USD | -2837.59% |
| 2013 Q2 | -187.11 Thousand USD | 57.73% |
| 2013 Q3 | -376.68 Thousand USD | -101.31% |
| 2012 Q2 | -275.8 Thousand USD | 38.22% |
| 2012 Q1 | -446.42 Thousand USD | 30.14% |
| 2012 FY | -869.24 Thousand USD | -29.72% |
| 2012 Q3 | -178.49 Thousand USD | 35.28% |
| 2012 Q4 | -15.06 Thousand USD | 91.56% |
| 2011 Q2 | -8722.64 USD | -50.71% |
| 2011 Q3 | -10.4 Thousand USD | -19.33% |
| 2011 Q4 | -638.98 Thousand USD | -6038.74% |
| 2011 FY | -670.09 Thousand USD | -381.91% |
| 2011 Q1 | -5787.83 USD | 95.07% |
| 2010 FY | -139.05 Thousand USD | 0.0% |
| 2010 Q3 | -2827.20 USD | 84.42% |
| 2010 Q2 | -18.14 Thousand USD | 0.0% |
| 2010 Q4 | -117.3 Thousand USD | -4049.22% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| AI/ML Innovations Inc. | -1.66 Million CAD | -26.189% |
| Diagnamed Holdings Corp. | -1.17 Million CAD | -78.396% |
| Pangenomic Health Inc. | -2.71 Million CAD | 22.527% |
| nDatalyze Corp. | -316.56 Thousand CAD | -563.666% |
| Treatment.Com International Inc. | -2.32 Million CAD | 9.714% |
| Unidoc Health Corp. | -2.2 Million CAD | 4.532% |